Cabaletta Bio(CABA.US)

Last Updated 19:00:00 ET
longbridge loading

Analyst Reiterates Buy on Cabaletta Bio, Citing Strong Non-Preconditioned PV Data, Scalable Manufacturing, and Multiple Upcoming Catalysts

Tip Ranks·
US
CABA
-0.61%
US
LABU
-2.35%
US
XBI
-0.69%
Tip Ranks·
US
CABA
-0.61%
US
LABU
-2.35%
US
XBI
-0.69%

Cabaletta Bio | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
CABA
-0.61%
Earnings Watch·
US
CABA
-0.61%

Cabaletta Bio | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
CABA
-0.61%
Earnings Watch·
US
CABA
-0.61%

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update | CABA Stock News

StockTitan·
US
CABA
-0.61%
US
XBI
-0.69%
US
SBIO
-1.24%
StockTitan·
US
CABA
-0.61%
US
XBI
-0.69%
US
SBIO
-1.24%

U.S. stock night market fluctuations: Cabaletta Bio rose 7.57% in the night market, boosted by a combination of $150 million financing and positive clinical data, driving the stock price surge

Price Alert·
US
CABA
-0.61%
Price Alert·
US
CABA
-0.61%

Cabaletta Bio Maintained at Buy as Emerging Rese-cel Data Support Preconditioning-Free Potential; $13 Price Target Reaffirmed

Tip Ranks·
US
CABA
-0.61%
US
FBT
+0.54%
US
IXJ
+0.79%
Tip Ranks·
US
CABA
-0.61%
US
FBT
+0.54%
US
IXJ
+0.79%

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga_article·
US
CNSP
+1.49%
US
MNDR
-0.01%
US
CABA
-0.61%
benzinga_article·
US
CNSP
+1.49%
US
MNDR
-0.01%
US
CABA
-0.61%

Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday

benzinga_article·
US
CELC
-0.82%
US
GBTG
-0.21%
US
AURA
-1.07%
benzinga_article·
US
CELC
-0.82%
US
GBTG
-0.21%
US
AURA
-1.07%
© 2026 Longbridge｜Disclaimer